Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in J Gen Virol

Retrieve available abstracts of 109 articles:
HTML format

Single Articles

    September 2021
  1. STALLER E, Sheppard CM, Baillon L, Frise R, et al
    A natural variant in ANP32B impairs influenza virus replication in human cells.
    J Gen Virol. 2021;102.
    PubMed     Abstract available

    August 2021
  2. HIRST JC, Hutchinson EC
    Corrigendum: Single-particle measurements of filamentous influenza virions reveal damage induced by freezing.
    J Gen Virol. 2021;102.

  3. RAHMAN F, Libre C, Oleinikov A, Tcherniuk S, et al
    Chloroquine and pyrimethamine inhibit the replication of human respiratory syncytial virus A.
    J Gen Virol. 2021;102.
    PubMed     Abstract available

    July 2021
  4. POHL MO, Busnadiego I, Marrafino F, Wiedmer L, et al
    Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir.
    J Gen Virol. 2021;102.
    PubMed     Abstract available

    June 2021
  5. ELGENDY EM, Arai Y, Kawashita N, Isobe A, et al
    Double mutations in the H9N2 avian influenza virus PB2 gene act cooperatively to increase viral host adaptation and replication for human infections.
    J Gen Virol. 2021;102.
    PubMed     Abstract available

  6. CHAPPELL JG, Tsoleridis T, Clark G, Berry L, et al
    Retrospective screening of routine respiratory samples revealed undetected community transmission and missed intervention opportunities for SARS-CoV-2 in the United Kingdom.
    J Gen Virol. 2021;102.
    PubMed     Abstract available

    May 2021
  7. DISSANAYAKE TK, Yan B, Ng AC, Zhao H, et al
    Differential role of sphingomyelin in influenza virus, rhinovirus and SARS-CoV-2 infection of Calu-3 cells.
    J Gen Virol. 2021;102.
    PubMed     Abstract available

  8. GOLDEN JW, Zeng X, Cline CR, Garrison AR, et al
    Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease.
    J Gen Virol. 2021;102.
    PubMed     Abstract available

  9. ZHANG QY, Deng CL, Liu J, Li JQ, et al
    SARS-CoV-2 replicon for high-throughput antiviral screening.
    J Gen Virol. 2021;102.
    PubMed     Abstract available

    April 2021
  10. HENSS L, Auste A, Schurmann C, Schmidt C, et al
    The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection.
    J Gen Virol. 2021;102.
    PubMed     Abstract available

  11. SMITHER SJ, Eastaugh LS, Findlay JS, Laws TR, et al
    Investigative study into whether an insect repellent has virucidal activity against SARS-CoV-2.
    J Gen Virol. 2021;102.
    PubMed     Abstract available

  12. PEACOCK TP, Penrice-Randal R, Hiscox JA, Barclay WS, et al
    SARS-CoV-2 one year on: evidence for ongoing viral adaptation.
    J Gen Virol. 2021;102.
    PubMed     Abstract available

  13. DAVIES K, Buczkowski H, Welch SR, Green N, et al
    Effective in vitro inactivation of SARS-CoV-2 by commercially available mouthwashes.
    J Gen Virol. 2021;102.
    PubMed     Abstract available

    March 2021
  14. MONCHATRE-LEROY E, Lesellier S, Wasniewski M, Picard-Meyer E, et al
    Hamster and ferret experimental infection with intranasal low dose of a single strain of SARS-CoV-2.
    J Gen Virol. 2021;102.
    PubMed     Abstract available

  15. GUPTA A, Sabarinathan R, Bala P, Donipadi V, et al
    A comprehensive profile of genomic variations in the SARS-CoV-2 isolates from the state of Telangana, India.
    J Gen Virol. 2021;102.
    PubMed     Abstract available

  16. ROE MK, Junod NA, Young AR, Beachboard DC, et al
    Targeting novel structural and functional features of coronavirus protease nsp5 (3CL(pro), M(pro)) in the age of COVID-19.
    J Gen Virol. 2021;102.
    PubMed     Abstract available

  17. AUERSWALD H, Yann S, Dul S, In S, et al
    Assessment of inactivation procedures for SARS-CoV-2.
    J Gen Virol. 2021;102.
    PubMed     Abstract available

  18. SIMMONDS P, Williams S, Harvala H
    Understanding the outcomes of COVID-19 - does the current model of an acute respiratory infection really fit?
    J Gen Virol. 2021;102.
    PubMed     Abstract available

    February 2021
  19. KHALIL AM, Yoshida R, Masatani T, Takada A, et al
    Variation in the HA antigenicity of A(H1N1)pdm09-related swine influenza viruses.
    J Gen Virol. 2021 Feb 22. doi: 10.1099/jgv.0.001569.
    PubMed     Abstract available

  20. CLEMENTS AL, Peacock TP, Sealy JE, Lee HM, et al
    PA-X is an avian virulence factor in H9N2 avian influenza virus.
    J Gen Virol. 2021 Feb 5. doi: 10.1099/jgv.0.001531.
    PubMed     Abstract available

    January 2021
  21. KIM DI, Cho YB, Lim Y, Hong SH, et al
    Chios mastic gum inhibits influenza A virus replication and viral pathogenicity.
    J Gen Virol. 2021 Jan 8. doi: 10.1099/jgv.0.001550.
    PubMed     Abstract available

  22. THAKUR N, Conceicao C, Isaacs A, Human S, et al
    Micro-fusion inhibition tests: quantifying antibody neutralization of virus-mediated cell-cell fusion.
    J Gen Virol. 2021;102.
    PubMed     Abstract available

    December 2020
  23. HARRIS M
    Microbiology Society online workshop on SARS-CoV-2 and COVID-19, Wednesday 29 July 2020.
    J Gen Virol. 2020;101:1227-1228.

    November 2020
  24. YU J, Li F, Wang D
    The first decade of research advances in influenza D virus.
    J Gen Virol. 2020 Nov 19. doi: 10.1099/jgv.0.001529.
    PubMed     Abstract available

  25. KLIMSTRA WB, Tilston-Lunel NL, Nambulli S, Boslett J, et al
    SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients.
    J Gen Virol. 2020;101:1156-1169.
    PubMed     Abstract available

    October 2020
  26. LI Y, Chai W, Min J, Ye Z, et al
    Neddylation of M1 negatively regulates the replication of influenza A virus.
    J Gen Virol. 2020 Oct 5. doi: 10.1099/jgv.0.001503.
    PubMed     Abstract available

  27. FIRTH AE
    A putative new SARS-CoV protein, 3c, encoded in an ORF overlapping ORF3a.
    J Gen Virol. 2020;101:1085-1089.
    PubMed     Abstract available

  28. SILVA SJRD, Germano Mendes RP, Alves da Silva CT, Lorusso A, et al
    Insights into SARS-CoV-2, the Coronavirus Underlying COVID-19: Recent Genomic Data and the Development of Reverse Genetics Systems.
    J Gen Virol. 2020;101:1021-1024.
    PubMed     Abstract available

  29. RENNICK LJ, Nambulli S, Lemon K, Olinger GY, et al
    Recombinant subtype A and B human respiratory syncytial virus clinical isolates co-infect the respiratory tract of cotton rats.
    J Gen Virol. 2020;101:1056-1068.
    PubMed     Abstract available

  30. RIJSBERGEN LC, Rennick LJ, Laksono BM, van Run PRWA, et al
    In vivo comparison of a laboratory-adapted and clinical-isolate-based recombinant human respiratory syncytial virus.
    J Gen Virol. 2020;101:1037-1046.
    PubMed     Abstract available

    September 2020
  31. MOOIJ P, Mortier D, Stammes M, Fagrouch Z, et al
    Aerosolized pH1N1 influenza infection induces less systemic and local immune activation in the lung than combined intrabronchial, nasal and oral exposure in cynomolgus macaques.
    J Gen Virol. 2020 Sep 25. doi: 10.1099/jgv.0.001489.
    PubMed     Abstract available

  32. WANG J, Xu X, Zhou X, Chen P, et al
    Molecular simulation of SARS-CoV-2 spike protein binding to pangolin ACE2 or human ACE2 natural variants reveals altered susceptibility to infection.
    J Gen Virol. 2020;101:921-924.
    PubMed     Abstract available

    August 2020
  33. KELLAM P, Barclay W
    The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.
    J Gen Virol. 2020;101:791-797.
    PubMed     Abstract available

    June 2020
  34. ZHANG T, Fan K, Zhang X, Xu Y, et al
    Diversity of avian influenza A(H5N6) viruses in wild birds in southern China.
    J Gen Virol. 2020 Jun 10. doi: 10.1099/jgv.0.001449.
    PubMed     Abstract available

    May 2020
  35. MAO L, Liang P, Li W, Zhang S, et al
    Exosomes promote caprine parainfluenza virus type 3 infection by inhibiting autophagy.
    J Gen Virol. 2020 May 19. doi: 10.1099/jgv.0.001424.
    PubMed     Abstract available

  36. MAJID NN, Omar AR, Mariatulqabtiah AR
    Negligible effect of chicken cytokine IL-12 integration into recombinant fowlpox viruses expressing avian influenza virus neuraminidase N1 on host cellular immune responses.
    J Gen Virol. 2020 May 19. doi: 10.1099/jgv.0.001428.
    PubMed     Abstract available

  37. EIDEN S, Dijkman R, Zell R, Fuchs J, et al
    Using a mouse-adapted A/HK/01/68 influenza virus to analyse the impact of NS1 evolution in codons 196 and 231 on viral replication and virulence.
    J Gen Virol. 2020 May 14. doi: 10.1099/jgv.0.001422.
    PubMed     Abstract available

    April 2020
  38. QIN Z, Qu X, Lei L, Xu L, et al
    Y-Box-Binding Protein 3 (YBX3) Restricts Influenza A Virus by Interacting with Viral Ribonucleoprotein Complex and Imparing its Function.
    J Gen Virol. 2020;101:385-398.
    PubMed     Abstract available

    March 2020
  39. MURR M, Karger A, Steglich C, Mettenleiter TC, et al
    Coexpression of soluble and membrane-bound avian influenza virus H5 by recombinant Newcastle disease virus leads to an increase in antigen levels.
    J Gen Virol. 2020 Mar 25. doi: 10.1099/jgv.0.001405.
    PubMed     Abstract available

    February 2020
  40. BRANTTIE JM, Dutch RE
    Parainfluenza virus 5 fusion protein maintains pre-fusion stability but not fusogenic activity following mutation of a transmembrane leucine/isoleucine domain.
    J Gen Virol. 2020 Feb 25. doi: 10.1099/jgv.0.001399.
    PubMed     Abstract available

    December 2019
  41. TEPPER V, Nykvist M, Gillman A, Skog E, et al
    Influenza A/H4N2 mallard infection experiments further indicate zanamivir as less prone to induce environmental resistance development than oseltamivir.
    J Gen Virol. 2019 Dec 19. doi: 10.1099/jgv.0.001369.
    PubMed     Abstract available

    November 2019
  42. BROWN JC, Barclay WS, Galiano M, Harvey R, et al
    Passage of influenza A/H3N2 viruses in human airway cells removes artefactual variants associated with neuraminidase-mediated binding.
    J Gen Virol. 2019 Nov 8. doi: 10.1099/jgv.0.001348.
    PubMed     Abstract available

    September 2019
  43. HIRST JC, Hutchinson EC
    Single-particle measurements of filamentous influenza virions reveal damage induced by freezing.
    J Gen Virol. 2019 Sep 26. doi: 10.1099/jgv.0.001330.
    PubMed     Abstract available

  44. NEMOTO M, Tamura N, Bannai H, Tsujimura K, et al
    Mutated influenza A virus exhibiting reduced susceptibility to baloxavir marboxil from an experimentally infected horse.
    J Gen Virol. 2019 Sep 17. doi: 10.1099/jgv.0.001325.
    PubMed     Abstract available

    August 2019
  45. UJIE M, Takada K, Kiso M, Sakai-Tagawa Y, et al
    Long-term culture of human lung adenocarcinoma A549 cells enhances the replication of human influenza A viruses.
    J Gen Virol. 2019 Aug 19. doi: 10.1099/jgv.0.001314.
    PubMed     Abstract available

    July 2019
  46. JAKUBCOVA L, Vozarova M, Holly J, Tomcikova K, et al
    Biological properties of influenza A virus mutants with amino acid substitutions in the HA2 glycoprotein of the HA1/HA2 interaction region.
    J Gen Virol. 2019 Jul 22. doi: 10.1099/jgv.0.001305.
    PubMed     Abstract available

  47. GAO W, Zu Z, Liu J, Song J, et al
    Prevailing I292V PB2 mutation in avian influenza H9N2 virus increases viral polymerase function and attenuates IFN-beta induction in human cells.
    J Gen Virol. 2019 Jul 15. doi: 10.1099/jgv.0.001294.
    PubMed     Abstract available

    June 2019
  48. HUSSAIN S, Turnbull ML, Pinto RM, McCauley JW, et al
    Segment 2 from influenza A(H1N1) 2009 pandemic viruses confers temperature-sensitive haemagglutinin yield on candidate vaccine virus growth in eggs that can be epistatically complemented by PB2 701D.
    J Gen Virol. 2019 Jun 6. doi: 10.1099/jgv.0.001279.
    PubMed     Abstract available

    May 2019
  49. LAMBERTZ RLO, Gerhauser I, Nehlmeier I, Leist SR, et al
    Tmprss2 knock-out mice are resistant to H10 influenza A virus pathogenesis.
    J Gen Virol. 2019 May 17. doi: 10.1099/jgv.0.001274.
    PubMed     Abstract available

  50. XU G, Wang F, Li Q, Bing G, et al
    Mutations in PB2 and HA enhanced pathogenicity of H4N6 avian influenza virus in mice.
    J Gen Virol. 2019 May 13. doi: 10.1099/jgv.0.001192.
    PubMed     Abstract available

    April 2019
  51. KOEL BF, Burke DF, van der Vliet S, Bestebroer TM, et al
    Epistatic interactions can moderate the antigenic effect of substitutions in haemagglutinin of influenza H3N2 virus.
    J Gen Virol. 2019 Apr 24. doi: 10.1099/jgv.0.001263.
    PubMed     Abstract available

  52. GONG YN, Tsao KC, Chen GW, Wu CJ, et al
    Population dynamics at neuraminidase position 151 of influenza A (H1N1)pdm09 virus in clinical specimens.
    J Gen Virol. 2019 Apr 17. doi: 10.1099/jgv.0.001258.
    PubMed     Abstract available

    March 2019
  53. KOOPMAN G, Mortier D, Michels S, Hofman S, et al
    Influenza virus infection as well as immunization with DNA encoding haemagglutinin protein induces potent antibody-dependent phagocytosis (ADP) and monocyte infection-enhancing responses in macaques.
    J Gen Virol. 2019 Mar 28. doi: 10.1099/jgv.0.001251.
    PubMed     Abstract available

    February 2019
  54. VRIJENS P, Noppen S, Boogaerts T, Vanstreels E, et al
    Influenza virus entry via the GM3 ganglioside-mediated platelet-derived growth factor receptor beta signalling pathway.
    J Gen Virol. 2019 Feb 14. doi: 10.1099/jgv.0.001235.
    PubMed     Abstract available

  55. POWELL TJ, Rijal P, McEwen-Smith RM, Byun H, et al
    A single cycle influenza virus coated in H7 haemagglutinin generates neutralizing antibody responses to haemagglutinin and neuraminidase glycoproteins and protection from heterotypic challenge.
    J Gen Virol. 2019 Feb 4. doi: 10.1099/jgv.0.001228.
    PubMed     Abstract available

    January 2019
  56. JAMES J, Smith N, Ross C, Iqbal M, et al
    The cellular localization of avian influenza virus PB1-F2 protein alters the magnitude of IFN2 promoter and NFkappaB-dependent promoter antagonism in chicken cells.
    J Gen Virol. 2019 Jan 23. doi: 10.1099/jgv.0.001220.
    PubMed     Abstract available

    November 2018
  57. SACRAMENTO CQ, Fintelman-Rodrigues N, Miranda M, Siqueira MM, et al
    Influenza virus RNA polymerase may be activated inside the virion.
    J Gen Virol. 2018 Nov 5. doi: 10.1099/jgv.0.001168.
    PubMed     Abstract available

    October 2018
  58. LI J, Hou G, Wang Y, Wang S, et al
    Protective efficacy of an inactivated chimeric H5 avian influenza vaccine against H5 highly pathogenic avian influenza virus clades and
    J Gen Virol. 2018 Oct 25. doi: 10.1099/jgv.0.001140.
    PubMed     Abstract available

    August 2018
  59. LAMBERTZ RLO, Pippel J, Gerhauser I, Kollmus H, et al
    Exchange of amino acids in the H1-haemagglutinin to H3 residues is required for efficient influenza A virus replication and pathology in Tmprss2 knock-out mice.
    J Gen Virol. 2018 Aug 6. doi: 10.1099/jgv.0.001128.
    PubMed     Abstract available

    June 2018
  60. BEER K, Dai M, Howell S, Rijal P, et al
    Characterization of neutralizing epitopes in antigenic site B of recently circulating influenza A(H3N2) viruses.
    J Gen Virol. 2018 Jun 26. doi: 10.1099/jgv.0.001101.
    PubMed     Abstract available

    April 2018
  61. MACHADO D, Pizzorno A, Hoffmann J, Traversier A, et al
    Role of p53/NF-kappaB functional balance in respiratory syncytial virus-induced inflammation response.
    J Gen Virol. 2018;99:489-500.
    PubMed     Abstract available

    March 2018
  62. STERTZ S, Paul Duprex W, Harris M
    A novel mutation in the neuraminidase gene of the 2009 pandemic H1N1 influenza A virus confers multidrug resistance.
    J Gen Virol. 2018;99:275-276.

  63. KWON JJ, Choi WS, Jeong JH, Kim EH, et al
    An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness.
    J Gen Virol. 2018;99:292-302.
    PubMed     Abstract available

    February 2018
  64. OHTA K, Matsumoto Y, Nishio M
    Human parainfluenza virus type 2 V protein inhibits caspase-1.
    J Gen Virol. 2018 Feb 27. doi: 10.1099/jgv.0.001037.
    PubMed     Abstract available

  65. SHENG Z, Liu R, Yu J, Ran Z, et al
    Identification and characterization of viral defective RNA genomes in influenza B virus.
    J Gen Virol. 2018 Feb 12. doi: 10.1099/jgv.0.001018.
    PubMed     Abstract available

  66. SAITO LB, Diaz-Satizabal L, Evseev D, Fleming-Canepa X, et al
    IFN and cytokine responses in ducks to genetically similar H5N1 influenza A viruses of varying pathogenicity.
    J Gen Virol. 2018 Feb 12. doi: 10.1099/jgv.0.001015.
    PubMed     Abstract available

    January 2018
  67. LAMONT EA, Poulin E, Sreevatsan S, Cheeran MC, et al
    Major histocompatibility complex I of swine respiratory cells presents conserved regions of influenza proteins.
    J Gen Virol. 2018 Jan 12. doi: 10.1099/jgv.0.001008.
    PubMed     Abstract available

    December 2017
  68. WHITE MC, Lowen AC
    Implications of segment mismatch for influenza A virus evolution.
    J Gen Virol. 2017 Dec 15. doi: 10.1099/jgv.0.000989.
    PubMed     Abstract available

  69. QI X, Zhang H, Xue T, Yang B, et al
    Down-regulation of cellular protein heme oxygenase-1 inhibits proliferation of avian influenza virus H9N2 in chicken oviduct epithelial cells.
    J Gen Virol. 2017 Dec 8. doi: 10.1099/jgv.0.000986.
    PubMed     Abstract available

    November 2017
  70. NAM JH, Song EJ, Song D, Espano E, et al
    Molecular and phylogenetic analyses of influenza B viruses isolated from pediatric inpatients in South Korea during the 2011-2012 winter season.
    J Gen Virol. 2017 Nov 23. doi: 10.1099/jgv.0.000983.
    PubMed     Abstract available

  71. NYKVIST M, Gillman A, Soderstrom Lindstrom H, Tang C, et al
    In vivo mallard experiments indicate that zanamivir has less potential for environmental influenza A virus resistance development than oseltamivir.
    J Gen Virol. 2017 Nov 15. doi: 10.1099/jgv.0.000977.
    PubMed     Abstract available

  72. TIAN D, Sooryanarain H, Matzinger SR, Gauger PC, et al
    Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus.
    J Gen Virol. 2017 Nov 1. doi: 10.1099/jgv.0.000964.
    PubMed     Abstract available

  73. PELLEGRINELLI L, Bubba L, Galli C, Anselmi G, et al
    Epidemiology and molecular characterization of influenza viruses, human parechoviruses and enteroviruses in children up to 5 years with influenza-like illness in Northern Italy during seven consecutive winter seasons (2010-2017).
    J Gen Virol. 2017;98:2699-2711.
    PubMed     Abstract available

    October 2017
  74. NELSON MI, Culhane MR, Trovao NS, Patnayak DP, et al
    The emergence and evolution of influenza A (H1alpha) viruses in swine in Canada and the United States.
    J Gen Virol. 2017 Oct 23. doi: 10.1099/jgv.0.000924.
    PubMed     Abstract available

    September 2017
  75. CIMINSKI K, Thamamongood T, Zimmer G, Schwemmle M, et al
    Novel insights into bat influenza A viruses.
    J Gen Virol. 2017 Sep 14. doi: 10.1099/jgv.0.000927.
    PubMed     Abstract available

  76. CLINE TD, Beck D, Bianchini E
    Influenza virus replication in macrophages: balancing protection and pathogenesis.
    J Gen Virol. 2017 Sep 8. doi: 10.1099/jgv.0.000922.
    PubMed     Abstract available

  77. LANGEVIN S, Pichon M, Smith E, Morrison J, et al
    Early nasopharyngeal microbial signature associated with severe influenza in children: a retrospective pilot study.
    J Gen Virol. 2017 Sep 8. doi: 10.1099/jgv.0.000920.
    PubMed     Abstract available

  78. PATZINA C, Botting CH, Garcia-Sastre A, Randall RE, et al
    Human interactome of the influenza B virus NS1 protein.
    J Gen Virol. 2017;98:2267-2273.
    PubMed     Abstract available

    August 2017
  79. TANIKAWA T, Uchida Y, Saito T
    Replication of a low-pathogenic avian influenza virus is enhanced by chicken ubiquitin-specific protease 18.
    J Gen Virol. 2017 Aug 22. doi: 10.1099/jgv.0.000890.
    PubMed     Abstract available

  80. HOA LNM, Tuan NA, My PH, Huong TTK, et al
    Assessing evidence for avian-to-human transmission of influenza A/H9N2 virus in rural farming communities in northern Vietnam.
    J Gen Virol. 2017 Aug 4. doi: 10.1099/jgv.0.000877.
    PubMed     Abstract available

    July 2017
  81. GAO S, Anderson TK, Walia RR, Dorman KS, et al
    The genomic evolution of H1 influenza A viruses from swine detected in the United States between 2009 and 2016.
    J Gen Virol. 2017 Jul 31. doi: 10.1099/jgv.0.000885.
    PubMed     Abstract available

  82. KANDEIL A, Kayed A, Moatasim Y, Webby RJ, et al
    Genetic characterization of highly pathogenic avian influenza A H5N8 viruses isolated from wild birds in Egypt.
    J Gen Virol. 2017 Jul 18. doi: 10.1099/jgv.0.000847.
    PubMed     Abstract available

  83. ZHOU J, Liu S, Chen Y, Fu Y, et al
    Identification of two novel functional tRNA-derived fragments induced in response to respiratory syncytial virus infection.
    J Gen Virol. 2017;98:1600-1610.
    PubMed     Abstract available

    June 2017
  84. PASICK J, Diederich S, Berhane Y, Embury-Hyatt C, et al
    Imbalance between innate antiviral and pro-inflammatory immune responses may contribute to different outcomes involving low- and highly pathogenic avian influenza H5N3 infections in chickens.
    J Gen Virol. 2017 Jun 21. doi: 10.1099/jgv.0.000801.
    PubMed     Abstract available

  85. DUCATEZ M, Sonnberg S, Crumpton JC, Rubrum A, et al
    Highly pathogenic avian influenza H5N1 clade and clade 2.3.4 viruses do not induce a clade-specific phenotype in mallard ducks.
    J Gen Virol. 2017 Jun 20. doi: 10.1099/jgv.0.000806.
    PubMed     Abstract available

  86. ABDUL-CADER MS, Ahmed-Hassan H, Amarasinghe A, Nagy E, et al
    Toll-like receptor (TLR)21 signalling-mediated antiviral response against avian influenza virus infection correlates with macrophage recruitment and nitric oxide production.
    J Gen Virol. 2017 Jun 14. doi: 10.1099/jgv.0.000787.
    PubMed     Abstract available

  87. LEYMARIE O, Meyer L, Tafforeau L, Lotteau V, et al
    Influenza virus protein PB1-F2 interacts with CALCOCO2 (NDP52) to modulate innate immune response.
    J Gen Virol. 2017 Jun 14. doi: 10.1099/jgv.0.000782.
    PubMed     Abstract available

  88. MOGLING R, Richard MJ, Vliet SV, Beek RV, et al
    Neuraminidase-mediated haemagglutination of recent human influenza A(H3N2) viruses is determined by arginine 150 flanking the neuraminidase catalytic site.
    J Gen Virol. 2017 Jun 13. doi: 10.1099/jgv.0.000809.
    PubMed     Abstract available

  89. ZHANG X, Xu G, Wang C, Jiang M, et al
    Enhanced pathogenicity and neurotropism of mouse-adapted H10N7 influenza virus are mediated by novel PB2 and NA mutations.
    J Gen Virol. 2017 Jun 8. doi: 10.1099/jgv.0.000770.
    PubMed     Abstract available

  90. NAGUIB MM, Grund C, Arafa AS, Abdelwhab EM, et al
    Heterologous post-infection immunity against Egyptian avian influenza virus (AIV) H9N2 modulates the course of subsequent infection by highly pathogenic AIV H5N1, but vaccination immunity does not.
    J Gen Virol. 2017 Jun 5. doi: 10.1099/jgv.0.000767.
    PubMed     Abstract available

    May 2017
  91. BARATELLI M, Pedersen LE, Trebbien R, Larsen LE, et al
    Identification of cross-reacting T-cell epitopes in structural and non-structural proteins of swine and pandemic H1N1 influenza A virus strains in pigs.
    J Gen Virol. 2017 May 30. doi: 10.1099/jgv.0.000748.
    PubMed     Abstract available

  92. LEE ACY, To KKW, Zhu H, Chu H, et al
    Avian influenza virus A H7N9 infects multiple mononuclear cell types in peripheral blood and induces dysregulated cytokine responses and apoptosis in infected monocytes.
    J Gen Virol. 2017 May 30. doi: 10.1099/jgv.0.000751.
    PubMed     Abstract available

    Influenza: a world of discoveries, outbreaks and controversy.
    J Gen Virol. 2017 May 23. doi: 10.1099/jgv.0.000812.
    PubMed     Abstract available

  94. HARA K, Kashiwagi T, Hamada N, Watanabe H, et al
    Basic amino acids in the N-terminal half of the PB2 subunit of influenza virus RNA polymerase are involved in both transcription and replication.
    J Gen Virol. 2017 May 22. doi: 10.1099/jgv.0.000750.
    PubMed     Abstract available

    January 2017
  95. MYAING M, Jumat R, Huong T, Tan BH, et al
    Truncated forms of the PA protein containing only the C-terminal domains are associated with the RNP complex within H1N1 influenza virus particles.
    J Gen Virol. 2017 Jan 27. doi: 10.1099/jgv.0.000721.
    PubMed     Abstract available

  96. HU M, Yuan S, Ye ZW, Singh K, et al
    PAN substitutions A37S, A37S/I61T and A37S/V63I attenuate the replication of H7N7 influenza A virus by impairing the polymerase and endonuclease activities.
    J Gen Virol. 2017 Jan 22. doi: 10.1099/jgv.0.000717.
    PubMed     Abstract available

  97. YANG J, Lee J, Ma J, Lang Y, et al
    Pathogenicity of modified bat influenza virus with different M genes and its reassortment potential with swine influenza A virus.
    J Gen Virol. 2017 Jan 18. doi: 10.1099/jgv.0.000715.
    PubMed     Abstract available

  98. ABENTE EJ, Kitikoon P, Lager KM, Gauger PC, et al
    A highly pathogenic avian-derived influenza virus H5N1 with 2009 pandemic H1N1 internal genes demonstrates increased replication and transmission in pigs.
    J Gen Virol. 2017;98:18-30.
    PubMed     Abstract available

    December 2016
  99. LEE J, Henningson J, Ma J, Duff M, et al
    Effects of PB1-F2 on the pathogenicity of H1N1 swine influenza virus in mice and pigs.
    J Gen Virol. 2016 Dec 23. doi: 10.1099/jgv.0.000695.
    PubMed     Abstract available

  100. KUAH LF, Tang LH, Sutton T, Lim JH, et al
    Induction of protective immunity against influenza A/Jiangxi-Donghu/346/2013 (H10N8) in mice.
    J Gen Virol. 2016 Dec 15. doi: 10.1099/jgv.0.000683.
    PubMed     Abstract available

  101. KILLIP MJ, Jackson D, Perez-Cidoncha M, Fodor E, et al
    Single-cell studies of IFN-beta promoter activation by wildtype and NS1-defective influenza A viruses.
    J Gen Virol. 2016 Dec 15. doi: 10.1099/jgv.0.000687.
    PubMed     Abstract available

  102. ABENTE EJ, Kitikoon P, Lager KM, Gauger PC, et al
    A highly pathogenic avian influenza virus H5N1 with 2009 pandemic H1N1 internal genes demonstrates increased replication and transmission in pigs.
    J Gen Virol. 2016 Dec 9. doi: 10.1099/jgv.0.000678.
    PubMed     Abstract available

  103. ELGENDY EM, Arai Y, Kawashita N, Daidoji T, et al
    Identification of polymerase gene mutations that affect viral replication in H5N1 influenza viruses isolated from pigeons.
    J Gen Virol. 2016 Dec 7. doi: 10.1099/jgv.0.000674.
    PubMed     Abstract available

    November 2016
  104. WANG Z, Kedzierska L, Nuessing S, Chua B, et al
    Establishment of memory CD8+ T cells with live attenuated influenza virus (LAIV) across different vaccination doses.
    J Gen Virol. 2016 Nov 2. doi: 10.1099/jgv.0.000651.
    PubMed     Abstract available

    October 2016
  105. ABDELWHAB EM, Veits J, Tauscher K, Ziller M, et al
    Progressive glycosylation of the hemagglutinin of avian influenza H5N1 modulates virus replication, virulence and chicken-to-chicken transmission without significant impact on antigenic drift.
    J Gen Virol. 2016 Oct 28. doi: 10.1099/jgv.0.000648.
    PubMed     Abstract available

  106. QI X, Zhang H, Wang Q, Wang J, et al
    The NS1 protein of avian influenza virus H9N2 induces oxidative stress-mediated chicken oviduct epithelial cells (COECs) apoptosis.
    J Gen Virol. 2016 Oct 20. doi: 10.1099/jgv.0.000625.
    PubMed     Abstract available

    September 2016
  107. SADEWASSER A, Saenger S, Paki K, Schwecke T, et al
    J Gen Virol. 2016 Sep 16. doi: 10.1099/jgv.0.000604.
    PubMed     Abstract available

  108. MESMAN AW, Westerhuis BM, Ten Hulscher HI, Jacobi RH, et al
    Influenza virus A(H1N1)2009 antibody-dependent cellular cytotoxicity in young children prior to the H1N1 pandemic.
    J Gen Virol. 2016;97:2157-65.
    PubMed     Abstract available

    June 2016
  109. SWETT-TAPIA C, Bogaert L, de Jong P, van Hoek V, et al
    Recombinant measles virus incorporating heterologous viral membrane proteins for use as vaccines.
    J Gen Virol. 2016 Jun 15. doi: 10.1099/jgv.0.000523.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.